Natural evolution of experimental vitreous hemorrhage and effects of corticosteroids on its course.

نویسنده

  • Dragan Vuković
چکیده

INTRODUCTION The course and prognosis of vitreous hemorrhage (VH) are difficult to predict in spite of so far published experimental and clinical studies. OBJECTIVE The goal of this study was to follow the course and evaluate prognosis of vitreous hemorrhage. METHODS The experiment was performed on 19 Chinchilla rabbits (Oryctolagus cuniculus), both males and females (38 eyes), weighing 2500-3000 g, which were treated with autologous blood (B) from marginal ear vein--the first group, and the second group was treated with both blood and corticosteroids (B+CS). The course of vitreous hemorrhage was examined. RESULTS Our results have shown that the cellular reaction to vitreous hemorrhage is different, compared to hemorrhage in other types of tissue, which is due to absence of an early polymorphonuclear cellular reaction. Number of cells within vitreous body is very low. CONCLUSION Vitreous hemorrhage has unusual course followed by a small number of cells (mostly polymorphonuclear cells). This is most important fact why VH is cleared very slowly (about 6 to 9 weeks). CS has moderate influence on the acceleration ofVH absorption.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Systemic Treatment of Vitreous Inflammation

Non infectious vitreous inflammation is often vision threatening and can be associated with potentially life-threatening systemic conditions. Treatment is often challenging as it involves systemic medications that can be associated with adverse effects. The classes of drugs are ever expanding and include corticosteroids, antimetabolites, alkylating agents, T-cell and calcineurin agents, biologi...

متن کامل

پارگی شبکیه، خونریزی ویتره و چین‌خوردگی ماکولا، 15 ماه بعد از لیزر عیوب انکساری: گزارش مورد

A 44 year old woman presented with decreased vision and floaters, started since 4 days before, in her right eye referred to our ophthalmology clinic. On examination, it was found that the best corrected visual acuity was limited to R-E: 20/80 and that of the left eye: 20/20. Fundus examination of the right eye revealed a rhegmatogenous subclinical retinal detachment and vitreous hemorrhage 15 m...

متن کامل

Eales disease: no typical clinical presentation

Eales disease is clinically manifested by retinal phlebitis, the onset of ischemia and retinal vessels neo area is often revealed by vitreous hemorrhage. Its etiology remains unknown. The management of this disease depends on the clinical presentation. Our patient was 27 years old, consults for a progressive loss of visual acuity unilateral in her left eye. On fundus exam at the emergency depar...

متن کامل

Corticosteroid Treatment in Diabetic Macular Edema

Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial. For many years, laser photocoagulation has been considered the standard therapy for the treatment of diabetic macular edema; however, few patients achieve significant improvements in visual acuity. Today the intravitreal admini...

متن کامل

Recurrent Vitreous Hemorrhage from an Optic Nerve Retinal Arterial Macroaneurysm

Objective To report a case of recurrent vitreous hemorrhage from an optic nerve retinal arterial macroaneurysm (ONRAM) successfully treated with intraoperative endolaser. Patient and Methods A 92-year-old woman on oral aspirin and warfarin anticoagulation for atrial fibrillation developed three episodes of dense vitreous hemorrhage from an ONRAM. Due to failure of the vitreous hemorrhage to c...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Srpski arhiv za celokupno lekarstvo

دوره 141 11-12  شماره 

صفحات  -

تاریخ انتشار 2013